This inventor holds 3 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1992-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hatsudo, JP (1993)
- Matsudo, JP (1992 - 2003)
Company Filing History:
Years Active: 1992-2003
Title: The Innovations of Tadahiro Matsushita
Introduction
Tadahiro Matsushita is a notable inventor based in Matsudo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of proteins that inhibit bacterial DNA gyrase activity. With a total of 3 patents to his name, Matsushita continues to push the boundaries of scientific innovation.
Latest Patents
Matsushita's latest patents include groundbreaking work on DNA gyrase-inhibiting proteins. This invention discloses a protein that possesses the ability to inhibit bacterial DNA gyrase activity, known as DNA Gyrase-inhibiting protein (DGI). The patent also covers a host cell transformed by a replicable expression vector that encodes DGI, a process for preparing DGI through culturing, and methods for identifying medical compounds by assaying the action of modulating the DNA gyrase-inhibiting activity of DGI. Additionally, he has developed a mercaptan compound characterized by a specific formula, which includes variations of hydrogen atoms or lower alkyl groups.
Career Highlights
Matsushita is currently associated with Tanabe Seiyaku Company, Limited, where he applies his expertise in biotechnology. His work has been instrumental in advancing the understanding of bacterial resistance and potential therapeutic applications.
Collaborations
Matsushita has collaborated with esteemed colleagues such as Kazuhiko Kondo and Hiroshi Horikawa, contributing to a rich environment of innovation and research.
Conclusion
Tadahiro Matsushita's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to inspire advancements in medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile